Knochengesundheit, Biocon

Knochengesundheit: Biocon Biologics erhält positive CHMP-Stellungnahmen für das Biosimilar Denosumab in Europa

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

Biocon Biologics Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom India Europe

View original content:https://www.prnewswire.com/news-releases/knochengesundheit-biocon-biologics-erhalt-positive-chmp-stellungnahmen-fur-das-biosimilar-denosumab-in-europa-302438980.html

en | boerse | 67926447 |